Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Prostate cancer is the most common cancer in UK men, with around 63,000 new cases diagnosed each year, affecting one in eight ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

Prostate cancer is the second-leading cause of cancer death among American men. With 1 in 8 facing this diagnosis over his lifetime, according to the American Cancer Society, curiosity about natural ...

We know that aerobic exercise – anything that gets you sweaty, your heart rate up or out of breath for 20 minutes a day – is ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Prostate cancer risk factors include some that can’t be changed, such as having a family history of the disease and a genetic predisposition for developing the cancer ...

IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...